Medgenics Inc entered the industry of Biotherapeutics in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417114, which describes it as a Biotherapeutics. For further clarification, the SIC classifies this business under the code 5122 and described it as a Biotherapeutics. The business provides service to the BOTH market.
To acquire more information, please contact Andrew Pearlman, Chief Executive Officer by calling (415) 568-2245 during business hours. You can also write to the business’ Headquarters at 555 California St, San Francisco, California CA 94104. You can also visit the company’s website at medgenics.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Medgenics Inc |
| Representative: | Andrew Pearlman, Chief Executive Officer |
| Place of Business: | 555 California St, San Francisco, CA 94104 |
| Contact Number: | (415) 568-2245 |
| Website: | medgenics.com |
| Type of Service: | Biotherapeutics |
| SIC Number: | 5122 |
| NAICS Number: | 5417114 |
| Locality: | Headquarters |
| Market Type: | B2B & B2C |
| Began: | 2002 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Medgenics Inc is a company operating from San Francisco, California providing professional Biotherapeutics and relevant BOTH variables. It was founded in 2002 and registered with the SIC code 5122 as Biotherapeutics, and with the NAICS code 5417114 as Biotherapeutics.
With a current employee count of 1 to 4, Medgenics Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Andrew Pearlman, Chief Executive Officer at (415) 568-2245 for related queries, or to locate its Headquarters using the coordinates 37.792656,-122.40388.
The Headquarters can also be found at the street address 555 California St in San Francisco, California 94104 and can be engaged online through the company website at medgenics.com, the company Twitter , and Facebook page .